Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|48|10|2881-2887

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.48, Iss.10, 2003-10, pp. : 2881-2887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic Lupus Erythematosus: 50% of Patients Experience Kidney Damage

By  

Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. : 32-36

Adis International

Access to resources Recommend Favorite

Assessment of Inhomogeneities of Repolarization in Patients with Systemic Lupus Erythematosus

By Avci Ahmet   Demir Kenan   Altunkeser Bulent Behlul   Yilmaz Sema   Yilmaz Ahmet   Ersecgin Ahmet   Demir Tarik  

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 4, 2014-07 ,pp. : 374-382

Blackwell Publishing

Access to resources Recommend Favorite

Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach

By  

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1261-1269

Bentham Science Publishers

Access to resources Recommend Favorite

The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage

By Lv Jun-qiang   Zhang Wen   Wang Song   Zhao Lin   Ma Rui   Hu Jin-wei   Wang Li-juan   Meng Jie   Zhou Chun-lei   Lin Gang   Lu Rong   Yao Zhi  

Inflammation Research, Vol. 59, Iss. 12, 2010-12 ,pp. : 1081-1089

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa   Perl Andras  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite